Albireo announces exclusive licensing agreement with jadeite medicines for bylvay™ (odevixibat) in japan

– agreement to accelerate commercialization of bylvay™ (odevixibat) in japan, a significant market for pfic, alagille syndrome and biliary atresia –

ALBO Ratings Summary

ALBO Quant Ranking